Abstract
Depression is disproportionately prevalent among individuals with diabetes compared to the general populace, underscoring the critical need for predictive mechanisms that can facilitate timely interventions and support. This study explores the use of machine learning to forecast depression in those at risk or diagnosed with diabetes, leveraging the extensive primary care data from the Canadian Primary Care Sentinel Surveillance Network. Six machine learning models including Logistic Regression, Random Forest, AdaBoost, XGBoost, Naive Bayes, and Artificial Neural Networks were trained and evaluated on their ability to predict depression. XGBoost emerged as the most effective model with an AUC of 0.70 on the test data. Sex, age, osteoarthritis, A1c levels, and body mass index emerged as the key contributors to the bestperforming model’s predictive ability. While the study navigated through the constraints of limited demographic information and potential label bias, it lays a foundational premise for subsequent longitudinal studies aimed at refining depression prediction within this specific clinical cohort.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
zahra.shakeri{at}utoronto.ca
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos